DrugPatentWatch Database Preview
Stiefel Company Profile
» See Plans and Pricing
What is the competitive landscape for STIEFEL, and what generic and branded alternatives to STIEFEL drugs are available?
STIEFEL has five approved drugs.
Summary for Stiefel
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
| Patent Litigation for Stiefel: | See patent lawsuits for Stiefel |
Drugs and US Patents for Stiefel
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-001 | Oct 28, 1996 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-004 | Aug 6, 2009 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Stiefel | DUAC | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050741-001 | Aug 26, 2002 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Stiefel | SCABENE | lindane | LOTION;TOPICAL | 086769-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Stiefel Labs Inc | SORIATANE | acitretin | CAPSULE;ORAL | 019821-002 | Oct 28, 1996 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Stiefel
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Stiefel | DUAC | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050741-001 | Aug 26, 2002 | 5,466,446 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for STIEFEL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Gel | 1% / 5% | ➤ Subscribe | 2008-12-11 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
